- The Bach model, Ovarian Cancer Screening Trial Model 2012 (PLCO-M2012), Lung Cancer Risk Assessment Tool (LCRAT), and Lung Cancer Death Risk Assessment Tool (LCDRAT) best identify candidates for CT screening among smokers/former smokers.
Why this matters
- In the absence of thresholds for screening, 2018 National Comprehensive Cancer Network guidelines advise using risk-prediction models.
- 2010-2012 National Health Interview survey data simulated a US screening population.
- Validity was assessed using data for 337,388 ever-smokers in the NIH-American Association of Retired Persons Diet and Health Study and 72,338 ever-smokers in the Cancer Prevention Study II Nutrition Survey cohort.
- Funding: NIH/National Cancer Institute.
- At a 5-year threshold of 2.0%, screening populations ranged from 7.6 to 26 million.
- Bach, PLCO-M2012, LCRAT, and LCDRAT showed greater agreement on screening population size (7.6-10.9 million) and achieved consensus on proportion of selected ever-smokers (73%).
- These 4 models had the highest overall discrimination, highest sensitivity at a fixed specificity (and vice versa), and similar discrimination at a fixed risk threshold.
- All 4 had limitations:
- Bach did not account for race/ethnicity, COPD, or family history of lung cancer.
- PLCO-M2012 underestimated risk in Hispanics by 2- to 3-fold.
- LCRAT/LCDRAT underestimated risk in Asian/other subgroup.
- May not represent contemporary US population.